Aaron Berg
Vermögen: 25 Mio $ am 31.05.2026
Vermögen: 25 Mio $ am 31.05.2026
Aaron D.
Berg currently serves as President, Chief Executive Officer & Director at Amarin Corp.
Plc since 2024 and holds a Director position at the American Heart Association, Inc. Formerly, Mr. Berg was President, Chief Executive Officer & Director at Essentialis, Inc. from 2009 to 2012.
Other previous roles include Principal at Bristol Myers Squibb Co., Vice President-Marketing at Oscient Pharmaceuticals Corp., Principal at Schering-Plough Corp., Vice President-Marketing at KOS Pharmaceuticals, Inc. from 2001 to 2015, and Principal at GlaxoSmithKline, Inc. Education includes undergraduate studies at the University of Maryland.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
AMARIN CORPORATION 0,4 % | 16.03.2026 | 1 651 900 ( 0,4 % ) | 24 Mio $ | 31.05.2026 |
| 31.01.2025 | 44 077 ( 0,21 % ) | 638 676 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AMARIN CORPORATION PLC | Vorstandsvorsitzender | 04.06.2024 |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Direktor/Vorstandsmitglied | 28.07.2011 |
| Unternehmen | Position | Ende |
|---|---|---|
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Vorstandsvorsitzender | - |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Corporate Officer/Principal | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Markets and sells products to community-based primary care physicians | Commercial Services |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Amarin Corp. Plc
Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen